Remove 2009 Remove Dosage Remove Pharmaceutical Companies
article thumbnail

Tracking the Drug Trail

Pharmaceutical Technology

Pharmaceutical companies, regulatory agencies and governments are becoming increasingly concerned about fraud and counterfeiting throughout the pharmaceutical supply chain, especially with the cost of drugs going up. Combining methods of coding for both end solutions has, in the past, been the biggest challenge. .

article thumbnail

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

PharmaShots

Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years. No generic version of Entresto has been approved in the US.

FDA 49
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Systemwide Approach to Managing the Risks of Continuous Manufacturing

ISPE

Advanced technologies such as CM have the potential to greatly transform pharmaceutical production processes by improving drug quality and supply continuity for consumers worldwide while benefiting the company’s bottom line. ICH Q10 Pharmaceutical Quality System.” April 2009. November 2022. Guidance for Industry.

article thumbnail

Top 20 Radiopharma Companies Based on Market Cap

PharmaShots

The company expects to commence P-I clinical trials on metastatic and pediatric primary bone cancer patients. Other radiotherapies under the company's pipeline include Humalutin and Alpha37. The company is evaluating Iomab-B in a P-III clinical trial (SIERRA) in patients with relapsed or refractory acute myeloid leukemia (AML).

FDA 56
article thumbnail

Agile, Data-Driven Life Cycle Management for Continuous Manufacturing

ISPE

Going up in scale, in a CONTINUUS Pharmaceuticals and MIT collaboration, an end-to-end, QbD-driven integrated continuous manufacturing (ICM) pilot plant 8 was designed to produce both small molecule active pharmaceutical ingredient (API) and oral solid dosages. In 2021, CONTINUUS Pharmaceuticals secured a$69.3